# Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/liraglutide-a-long-acting-human-glucagon-like-peptide-1-analog-given-as/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tina Vilsbøll,Milan Zdravkovic,T Le-Thi,Thure Krarup,Ole Schmitz,J.P. Courrèges,Rob H.A. Verhoeven,Ingrid Bugáňová,Sten Madsbad |
| Citations | 471 |
| DOI | 10.2337/dc06-2593 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://diabetesjournals.org/care/article-pdf/30/6/1608/598008/zdc00607001608.pdf |
| OpenAlex ID | https://openalex.org/W2103525547 |
| PMID | 17372153 |
| Type | article |
| Year | 2007 |

## Paper authors

- [Tina Vilsbøll](https://scholariq.org/researchers/tina-vilsb-ll/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.